Literature DB >> 33158935

Deletion of Yy1 in mouse lung epithelium unveils molecular mechanisms governing pleuropulmonary blastoma pathogenesis.

Kim Landry-Truchon1, Nicolas Houde1, Mickaël Lhuillier2, Louis Charron1, Alice Hadchouel2,3, Christophe Delacourt2,3, William D Foulkes4, Louise Galmiche-Rolland3, Lucie Jeannotte5,6.   

Abstract

Pleuropulmonary blastoma (PPB) is a very rare pediatric lung disease. It can progress from abnormal epithelial cysts to an aggressive sarcoma with poor survival. PPB is difficult to diagnose as it can be confounded with other cystic lung disorders, such as congenital pulmonary airway malformation (CPAM). PPB is associated with mutations in DICER1 that perturb the microRNA (miRNA) profile in lung. How DICER1 and miRNAs act during PPB pathogenesis remains unsolved. Lung epithelial deletion of the Yin Yang1 (Yy1) gene in mice causes a phenotype mimicking the cystic form of PPB and affects the expression of key regulators of lung development. Similar changes in expression were observed in PPB but not in CPAM lung biopsies, revealing a distinctive PPB molecular signature. Deregulation of molecules promoting epithelial-mesenchymal transition (EMT) was detected in PPB specimens, suggesting that EMT might participate in tumor progression. Changes in miRNA expression also occurred in PPB lung biopsies. miR-125a-3p, a candidate to regulate YY1 expression and lung branching, was abnormally highly expressed in PPB samples. Together, these findings support the concept that reduced expression of YY1, due to the abnormal miRNA profile resulting from DICER1 mutations, contributes to PPB development via its impact on the expression of key lung developmental genes.This article has an associated First Person interview with the joint first authors of the paper.
© 2020. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Congenital pulmonary airway malformation; EMT; Lung development; Pleuropulmonary blastoma; YY1; miR-125a-3p

Year:  2020        PMID: 33158935      PMCID: PMC7790197          DOI: 10.1242/dmm.045989

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  71 in total

Review 1.  Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition.

Authors:  Amparo Cano; M Angela Nieto
Journal:  Trends Cell Biol       Date:  2008-06-26       Impact factor: 20.808

2.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model.

Authors:  Mark Brenneman; Amanda Field; Jiandong Yang; Gretchen Williams; Leslie Doros; Christopher Rossi; Kris Ann Schultz; Avi Rosenberg; Jennifer Ivanovich; Joyce Turner; Heather Gordish-Dressman; Douglas Stewart; Weiying Yu; Anne Harris; Peter Schoettler; Paul Goodfellow; Louis Dehner; Yoav Messinger; D Ashley Hill
Journal:  F1000Res       Date:  2015-07-10

3.  MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.

Authors:  Chuangzhou Rao; Xiaobo Miao; Guofang Zhao; Chen Zhang; Haibo Shen; Caijun Dong; Minglei Yang
Journal:  Biomed Pharmacother       Date:  2019-04-15       Impact factor: 6.529

4.  Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities.

Authors:  Brian D Harfe; Paul J Scherz; Sahar Nissim; Hua Tian; Andrew P McMahon; Clifford J Tabin
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

5.  FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains.

Authors:  Andrew C White; Jingsong Xu; Yongjun Yin; Craig Smith; Gregory Schmid; David M Ornitz
Journal:  Development       Date:  2006-03-15       Impact factor: 6.868

6.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

Review 7.  Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry.

Authors:  Dana Ashley Hill; Jason A Jarzembowski; John R Priest; Gretchen Williams; Peter Schoettler; Louis P Dehner
Journal:  Am J Surg Pathol       Date:  2008-02       Impact factor: 6.394

8.  Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry.

Authors:  Yoav H Messinger; Douglas R Stewart; John R Priest; Gretchen M Williams; Anne K Harris; Kris Ann P Schultz; Jiandong Yang; Leslie Doros; Philip S Rosenberg; D Ashley Hill; Louis P Dehner
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

9.  FGF-Regulated ETV Transcription Factors Control FGF-SHH Feedback Loop in Lung Branching.

Authors:  John C Herriges; Jamie M Verheyden; Zhen Zhang; Pengfei Sui; Ying Zhang; Matthew J Anderson; Deborah A Swing; Yan Zhang; Mark Lewandoski; Xin Sun
Journal:  Dev Cell       Date:  2015-11-09       Impact factor: 12.270

10.  Semi-quantitative Determination of Protein Expression using Immunohistochemistry Staining and Analysis: An Integrated Protocol.

Authors:  Alexandra R Crowe; Wei Yue
Journal:  Bio Protoc       Date:  2019-12-20
View more
  1 in total

1.  Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer.

Authors:  Silvia Vivarelli; Luca Falzone; Caterina Maria Grillo; Benjamin Bonavida; Claudia Crimi; Ignazio La Mantia; Massimo Libra
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.